Iterum Therapeutics (ITRM) EPS (Basic) (2017 - 2022)
Historic EPS (Basic) for Iterum Therapeutics (ITRM) over the last 6 years, with Q4 2022 value amounting to -$0.41.
- Iterum Therapeutics' EPS (Basic) fell 400000.0% to -$0.41 in Q4 2022 from the same period last year, while for Dec 2022 it was -$3.63, marking a year-over-year decrease of 67234.04%. This contributed to the annual value of -$1.26 for FY2024, which is 5743.24% up from last year.
- Iterum Therapeutics' EPS (Basic) amounted to -$0.41 in Q4 2022, which was down 400000.0% from -$2.38 recorded in Q3 2022.
- Iterum Therapeutics' 5-year EPS (Basic) high stood at $0.31 for Q3 2021, and its period low was -$61.36 during Q1 2018.
- Moreover, its 5-year median value for EPS (Basic) was -$1.26 (2019), whereas its average is -$4.44.
- Its EPS (Basic) has fluctuated over the past 5 years, first soared by 15166.67% in 2021, then plummeted by 400000.0% in 2022.
- Over the past 5 years, Iterum Therapeutics' EPS (Basic) (Quarter) stood at -$2.78 in 2018, then soared by 41.37% to -$1.63 in 2019, then plummeted by 329.16% to -$6.99 in 2020, then surged by 99.86% to -$0.01 in 2021, then tumbled by 4000.0% to -$0.41 in 2022.
- Its last three reported values are -$0.41 in Q4 2022, -$2.38 for Q3 2022, and -$0.55 during Q2 2022.